FDA Approved: MYTESI — Supplemental Application (Napo Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Mytesi (crofelemer) submitted by Napo Pharmaceuticals, Inc. This action approves the supplemental NDA for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Mytesi (crofelemer)

Snippet

SUPPL AP for MYTESI (CROFELEMER)